IMMUNOVANT, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.05 USD | -1.77% |
|
-0.02% | -38.16% |
| 06-03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
| 05-30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNOVANT, INC. | Other Biotechnology & Medical Research | -1.75% | -0.02% | -38.16% | +38.96% | +166.14% | 3.88B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMVT Stock
- Charts Immunovant, Inc.
- Comparison Chart
